Related Experiment Video
Updated: Mar 26, 2026
07:13
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
18.9K
[SSRIs for adolescents with medically unexplained symptoms].
Suzanne C van Bronswijk1, Judith M Lionarons, Antonia Stupp
1Maastricht UMC+, Psychiatrie en Psychologie, afd. Kinder- en Jeugdpsychiatrie, Maastricht.
Nederlands Tijdschrift Voor Geneeskunde
|January 28, 2016
Summary
Medically unexplained symptoms (MUS) in adolescents can cause significant impairment. Selective serotonin reuptake inhibitors (SSRIs) show promise as an effective treatment, improving adolescent functioning.
Area of Science:
- Adolescent medicine
- Psychiatry
- Clinical psychology
Background:
- Medically unexplained symptoms (MUS) are common in adolescents, leading to healthcare overuse and functional difficulties.
- Existing treatments for adolescent MUS are often ineffective, incurring substantial societal costs.
Observation:
- Two 15-year-old girls with a history of severe MUS and affective symptoms presented with functional impairment.
- Previous treatments for these adolescents were unsuccessful.
Findings:
- Treatment with selective serotonin reuptake inhibitors (SSRIs) led to significant improvements in general functioning for both patients.
- These positive outcomes were sustained at four to five-month follow-up.
Implications:
- MUS significantly impacts adolescents, their families, and society.
- SSRIs represent a potential therapeutic option for adolescent MUS, warranting further investigation.
- Additional research is crucial to validate SSRI efficacy in adolescent populations.
Related Concept Videos
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.0K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.0K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
01:25Antidepressant Drugs: Overview
2.0K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.0K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
822
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
822
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
855
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
855